• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of May 29, 2013

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Red Blood Cells Leukocytes Reduced
Recall Number B-0941-13
Classification Class II
Code Info 20E34887, 20E34890, 20E34899, 20E34906, 20J98100, 20J98716, 20M38841, 20M38847, 20M38849, 20M3B852, 20M38854, 20M38872, 20VB3505, 20V83514, 20V83516, 20V83519, 20E34908, 20E34910, 20J98110, 20J98713, 20J98723, 20M38831, 20M38838, 20M38857, 20M38862, 20V83510, 20M38834, 20J98721, 20M38840, 20J98684, 20E34879, 20J98698, 20J98103, 20M38870, 20V83S21, 20J98718, 20E34885, 20E34894, 20M38856, 20M38858, 20M38866, 20J98677, 20M38864, 20M38869, 20J98688, 20E34901.
Product Distributed Qty 46 units
Reason For Recall Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.

Event Detail

Event Id 39991
Product Type Biologics
Status Terminated
Recalling Firm American National Red Cross (The)
City Salt Lake City
State UT
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2005-03-17
Initial Firm Notification of Consignee or Public Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution Pattern CA, OK, TX, UT, and NV
-
-